In a report released today, Robert Burns from H.C. Wainwright reiterated a Buy rating on MacroGenics (MGNX - Research Report), with a price target...
H.C. Wainwright analyst Robert Burns reiterated a Buy rating on MacroGenics (MGNX - Research Report) today and set a price target of $12.00. The...
JMP Securities analyst Silvan Tuerkcan maintained a Buy rating on MacroGenics (MGNX - Research Report) today and set a price target of $18.00. The...
BMO Capital analyst Etzer Darout maintained a Hold rating on MacroGenics (MGNX - Research Report) today and set a price target of $5.70. The...
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on MacroGenics (MGNX – Research Report), Castle...
In a report released on October 17, Kaveri Pohlman from BTIG maintained a Buy rating on MacroGenics (MGNX - Research Report), with a price target...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Gilead Sciences (GILD – Research Report...
E ratio of -1.11.https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-their-buy-rating-for-macrogenics-mgnx?utm_source=advfn.com&utm_mediu...
Biopharmaceutical company MacroGenics’ (NASDAQ:MGNX) stock is soaring today after it announced a collaboration with Gilead Sciences (NASDAQ:GILD...
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Belite Bio, Inc. ADR (BLTE – Research Report...
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Haemonetics (HAE – Research Report), MacroGenics...
JMP Securities analyst Silvan Tuerkcan maintained a Buy rating on MacroGenics (MGNX - Research Report) today and set a price target of $20.00. The...
E ratio of (1.28).https://www.tipranks.com/news/blurbs/macrogenics-mgnx-gets-a-hold-from-bmo-capital?utm_source=advfn.com&utm_medium=referral
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.